- Home
- MDWD vs EM Comparison
MDWD vs EM Comparison
Compare MDWD & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDWD
- EM
- Stock Information
- Founded
- MDWD 2000
- EM 2017
- Country
- MDWD Israel
- EM China
- Employees
- MDWD N/A
- EM N/A
- Industry
- MDWD Medicinal Chemicals and Botanical Products
- EM Other Consumer Services
- Sector
- MDWD Health Care
- EM Consumer Discretionary
- Exchange
- MDWD Nasdaq
- EM Nasdaq
- Market Cap
- MDWD 184.8M
- EM 297.2M
- IPO Year
- MDWD 2014
- EM 2021
- Fundamental
- Price
- MDWD $20.15
- EM $1.15
- Analyst Decision
- MDWD Strong Buy
- EM Strong Buy
- Analyst Count
- MDWD 1
- EM 1
- Target Price
- MDWD $25.00
- EM $1.00
- AVG Volume (30 Days)
- MDWD 78.0K
- EM 1.9M
- Earning Date
- MDWD 03-20-2025
- EM 03-27-2025
- Dividend Yield
- MDWD N/A
- EM 2.29%
- EPS Growth
- MDWD N/A
- EM N/A
- EPS
- MDWD N/A
- EM 0.03
- Revenue
- MDWD $19,720,000.00
- EM $269,745,696.00
- Revenue This Year
- MDWD $10.15
- EM N/A
- Revenue Next Year
- MDWD $25.62
- EM $6.16
- P/E Ratio
- MDWD N/A
- EM $35.33
- Revenue Growth
- MDWD N/A
- EM N/A
- 52 Week Low
- MDWD $11.04
- EM $0.46
- 52 Week High
- MDWD $24.00
- EM $1.18
- Technical
- Relative Strength Index (RSI)
- MDWD 57.75
- EM 81.97
- Support Level
- MDWD $18.73
- EM $1.11
- Resistance Level
- MDWD $19.73
- EM $1.17
- Average True Range (ATR)
- MDWD 0.78
- EM 0.03
- MACD
- MDWD 0.02
- EM -0.00
- Stochastic Oscillator
- MDWD 66.35
- EM 91.89
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.